NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

24 hedge funds and large institutions have $482K invested in InVivo Therapeutics Holdings Corp in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
1
Perkins Capital Management
Minnesota
$253K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$166K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$10K
4
Citadel Advisors
4
Citadel Advisors
Florida
$9K
5
UBS Group
5
UBS Group
Switzerland
$10K

Top Sellers

1
BCM
1
Bridgeway Capital Management
Texas
$0
2
PWM
2
Paulson Wealth Management
Illinois
$0
3
NCM
3
Next Capital Management
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
TF
26
TimeScale Financial
Massachusetts
$0 5 – –
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$0 30 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$0 2 +1 +100%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 1 +1 New
Barclays
31
Barclays
United Kingdom
$0 2 +2 New
1
2